Journal of Controlled Release, volume 330, pages 244-256
Intravital imaging of liposome behavior upon repeated administration: A step towards the development of liposomal companion diagnostic for cancer nanotherapy.
Naumenko Victor
1
,
Vodopyanov Stepan S
2, 3
,
Vlasova Kseniya Yu.
4, 5
,
Potashnikova Daria M.
6
,
Melnikov Pavel A
1
,
Vishnevskiy Daniil A
1
,
Garanina A. S.
7
,
Valikhov Marat P.
8
,
Lipatova Anastasiia V
9
,
Чехонин В. П.
4, 10
,
Majouga Alexander G.
3, 11
,
Abakumov Maxim A.
3, 4
1
10
Publication type: Journal Article
Publication date: 2021-02-01
Journal:
Journal of Controlled Release
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor: 10.8
ISSN: 01683659, 18734995
Pharmaceutical Science
Abstract
Accumulation of liposomal drugs into human tumors has substantial variability influencing the probability of positive response to the therapy. Therefore, it becomes very important to identify the eligibility of patients for various treatment options. The existing strategies of tumor stratification using companion diagnostics are based on the assumption that the initial and subsequent doses of nanoparticles (NP) behave in a sufficiently similar manner to enable a valuable prognosis. Here, we use a combination of in vivo imaging techniques to validate the applicability of magnetic liposomes (ML) as a reliable tool to predict whether or not the tumor would respond to nanomedicine therapy. The results demonstrated that liposome biodistribution, interactions with immune cells, and extravasation behavior in tumors were not affected by the pretreatment with liposomes 24 h prior to the repeat dosing. Co-administration of liposomal doxorubicin (DXR) and liposomes loaded with maghemite NP resulted in a high colocalization rate between two nanomedicines in tumors suggesting that neither contrast agent, nor chemotherapeutics altered biodistribution of liposomes. Based on magnetic resonance imaging of 4T1 tumors performed before and 6 h after ML treatment, animals were classified into high and low accumulation subgroups. Higher ML deposition in tumors was associated with a reduction in lesion size and enhanced survival in animals treated with liposomal DXR, but not with DXR alone. Given that liposomes are the most numerous class of clinically approved nanomedicines the development of safe and cost-effective liposomal companion diagnostic suitable for non-invasive imaging is of paramount importance for improving the efficacy of cancer therapy.
Citations by journals
1
|
|
International Journal of Molecular Sciences
|
International Journal of Molecular Sciences
1 publication, 10%
|
Advanced Drug Delivery Reviews
|
Advanced Drug Delivery Reviews
1 publication, 10%
|
ACS Nano
|
ACS Nano
1 publication, 10%
|
Molecular Pharmaceutics
|
Molecular Pharmaceutics
1 publication, 10%
|
Drug Delivery
|
Drug Delivery
1 publication, 10%
|
Advanced Science
|
Advanced Science
1 publication, 10%
|
iScience
|
iScience
1 publication, 10%
|
npj Vaccines
|
npj Vaccines
1 publication, 10%
|
1
|
Citations by publishers
1
2
|
|
Elsevier
|
Elsevier
2 publications, 20%
|
American Chemical Society (ACS)
|
American Chemical Society (ACS)
2 publications, 20%
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
1 publication, 10%
|
Taylor & Francis
|
Taylor & Francis
1 publication, 10%
|
Wiley
|
Wiley
1 publication, 10%
|
Springer Nature
|
Springer Nature
1 publication, 10%
|
1
2
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
{"yearsCitations":{"type":"bar","data":{"show":true,"labels":[2021,2022,2023],"ids":[0,0,0],"codes":[0,0,0],"imageUrls":["","",""],"datasets":[{"label":"Citations number","data":[2,5,3],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6"],"percentage":["20","50","30"],"barThickness":null}]},"options":{"indexAxis":"x","maintainAspectRatio":true,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":1,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Citations per year","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"journals":{"type":"bar","data":{"show":true,"labels":["International Journal of Molecular Sciences","Advanced Drug Delivery Reviews","ACS Nano","Molecular Pharmaceutics","Drug Delivery","Advanced Science","iScience","npj Vaccines"],"ids":[14627,12266,8724,19735,14854,4130,6073,20541],"codes":[0,0,0,0,0,0,0,0],"imageUrls":["\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/5YZtvLvkPZuc2JHOaZsjCvGSHFCuC3drUwN3YAc5_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp"],"datasets":[{"label":"","data":[1,1,1,1,1,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[10,10,10,10,10,10,10,10],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Journals","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"publishers":{"type":"bar","data":{"show":true,"labels":["Elsevier","American Chemical Society (ACS)","Multidisciplinary Digital Publishing Institute (MDPI)","Taylor & Francis","Wiley","Springer Nature"],"ids":[17,40,202,18,11,8],"codes":[0,0,0,0,0,0],"imageUrls":["\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/5YZtvLvkPZuc2JHOaZsjCvGSHFCuC3drUwN3YAc5_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp"],"datasets":[{"label":"","data":[2,2,1,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[20,20,10,10,10,10],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Publishers","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}}}
Metrics
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Naumenko V. et al. Intravital imaging of liposome behavior upon repeated administration: A step towards the development of liposomal companion diagnostic for cancer nanotherapy. // Journal of Controlled Release. 2021. Vol. 330. pp. 244-256.
GOST all authors (up to 50)
Copy
Naumenko V., Vodopyanov S. S., Vlasova K. Y., Potashnikova D. M., Melnikov P. A., Vishnevskiy D. A., Garanina A. S., Valikhov M. P., Lipatova A. V., Чехонин В. П., Majouga A. G., Abakumov M. A. Intravital imaging of liposome behavior upon repeated administration: A step towards the development of liposomal companion diagnostic for cancer nanotherapy. // Journal of Controlled Release. 2021. Vol. 330. pp. 244-256.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.jconrel.2020.12.014
UR - https://doi.org/10.1016%2Fj.jconrel.2020.12.014
TI - Intravital imaging of liposome behavior upon repeated administration: A step towards the development of liposomal companion diagnostic for cancer nanotherapy.
T2 - Journal of Controlled Release
AU - Naumenko, Victor
AU - Vodopyanov, Stepan S
AU - Vlasova, Kseniya Yu.
AU - Potashnikova, Daria M.
AU - Melnikov, Pavel A
AU - Vishnevskiy, Daniil A
AU - Garanina, A. S.
AU - Valikhov, Marat P.
AU - Lipatova, Anastasiia V
AU - Чехонин, В. П.
AU - Majouga, Alexander G.
AU - Abakumov, Maxim A.
PY - 2021
DA - 2021/02/01 00:00:00
PB - Elsevier
SP - 244-256
VL - 330
SN - 0168-3659
SN - 1873-4995
ER -
Cite this
BibTex
Copy
@article{2021_Naumenko,
author = {Victor Naumenko and Stepan S Vodopyanov and Kseniya Yu. Vlasova and Daria M. Potashnikova and Pavel A Melnikov and Daniil A Vishnevskiy and A. S. Garanina and Marat P. Valikhov and Anastasiia V Lipatova and В. П. Чехонин and Alexander G. Majouga and Maxim A. Abakumov},
title = {Intravital imaging of liposome behavior upon repeated administration: A step towards the development of liposomal companion diagnostic for cancer nanotherapy.},
journal = {Journal of Controlled Release},
year = {2021},
volume = {330},
publisher = {Elsevier},
month = {feb},
url = {https://doi.org/10.1016%2Fj.jconrel.2020.12.014},
pages = {244--256},
doi = {10.1016/j.jconrel.2020.12.014}
}